Familial Non-Autoimmune Hyperthyroidism (FNAH): A Patient Guide
At a Glance
Familial non-autoimmune hyperthyroidism is a rare inherited condition in which a change in a thyroid signal receptor gene keeps the thyroid overactive. Genetic counseling, regular monitoring, and sometimes surgery or radioactive iodine support long-term care.
Familial Non-Autoimmune Hyperthyroidism (FNAH) is a rare genetic condition that fundamentally changes how the body manages its metabolism. For many patients, the path to this diagnosis is long and marked by confusion, often involving years of being treated for more common thyroid issues that never quite seemed to fit. Unlike common autoimmune forms of hyperthyroidism (like Graves’ disease), this condition is not caused by an external attack from the immune system, but by an inherited change in the thyroid’s own genetic instructions [1].
At the heart of FNAH is a variation in the TSH receptor gene. This gene acts as a “switch” on the surface of your thyroid cells, designed to receive signals from the brain and tell the thyroid when to produce hormones. In FNAH, this genetic variation often keeps the switch stuck in the “on” position—a state known as constitutive activation. Because the thyroid is frequently overactive, it can constantly release hormones regardless of what the body actually needs. This persistent nature is why the condition rarely goes into remission on its own [2].
Because the condition is inherited in an autosomal dominant pattern, it often runs through family trees, though it can also appear for the first time in an individual. The experience of FNAH is highly personal; even within the same family, the age when symptoms first appear and how severe they feel can vary significantly. Some may require treatment in childhood, while others may not notice signs until much later in adulthood [3].
Living with FNAH means moving toward a goal of long-term stability. Because the thyroid’s overactivity is “programmed” into its DNA, many patients eventually discuss definitive treatments—such as surgery or radioactive iodine—with their endocrinologist to protect their long-term heart and bone health. While these decisions require careful consideration and specialized care, having a genetic answer provides a clear roadmap. Armed with this knowledge, you and your family can work with specialists and genetic counselors to establish a monitoring and care plan that protects your health for decades to come [4].
In this guide
6 chapters
Understanding Your FNAH Diagnosis
Learn how Familial Non-Autoimmune Hyperthyroidism (FNAH) differs from Graves’ disease, including TSHR mutations, antibody tests, inheritance, and treatment.
The Biology of FNAH
Learn how TSHR mutations cause familial non-autoimmune hyperthyroidism, how FNAH differs from Graves’ disease, and how genetic testing supports the diagnosis.
Symptoms and Variations Across Generations
Learn how familial non-autoimmune hyperthyroidism varies by age, from childhood growth changes to adult palpitations, and when heart symptoms need urgent care.
The Path to a Clear Diagnosis
Learn how familial non-autoimmune hyperthyroidism is diagnosed using thyroid blood tests, antibody testing, imaging, TSHR genetic testing, and family screening.
Treatment Options and Long-Term Management
Learn about familial hyperthyroidism treatment options: antithyroid drugs, thyroidectomy, radioactive iodine, and levothyroxine after definitive treatment.
Lifelong Monitoring and Family Health
Learn how familial non-autoimmune hyperthyroidism (FNAH) monitoring covers low TSH, tissue regrowth, pregnancy planning, and genetic testing for relatives.
Common questions in this guide
What causes familial non-autoimmune hyperthyroidism?
How is FNAH different from Graves’ disease?
Can FNAH run in families, and should relatives be tested?
Does familial hyperthyroidism go away on its own?
What treatments are used for FNAH?
What health monitoring is important with FNAH?
Get notified when new evidence is published on Familial hyperthyroidism due to mutations in TSH receptor.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (4)
- 1
TSHR Gly413Ser in familial nonautoimmune hyperthyroidism: a case report.
Kelp O, Førsvoll J, Bischof F, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; doi:10.1515/jpem-2025-0617.
PMID: 42665942 - 2
Report of a family with three generations of undiagnosed familial nonautoimmune hyperthyroidism.
Stephenson A, Punjwani Z, Eszlinger M, et al.
Endocrinology, diabetes & metabolism case reports 2021; (2021()).
PMID: 34866058 - 3
Novel presentation of the c.1856A > G (p.Asp619Gly) TSHR gene-activating variant: relapsing hyperthyroidism in three subsequent generations manifesting in early childhood and an in vitro functional study.
Bezdicka M, Kleiblova P, Soucek J, et al.
Hormones (Athens, Greece) 2021; (20(4)):803-812 doi:10.1007/s42000-021-00299-x.
PMID: 34142359 - 4
Familial Non-autoimmune Hyperthyroidism in Family Members Across Four Generations Due To a Novel Disease-causing Variant in The Thyrotropin Receptor Gene.
Malej A, Avbelj Stefanija M, Bratanič N, Trebušak Podkrajšek K
Balkan journal of medical genetics : BJMG 2020; (23(2)):87-92 doi:10.2478/bjmg-2020-0022.
PMID: 33816077
This page is for informational purposes only and does not constitute medical advice. Discuss genetic testing, treatment choices, and heart and bone monitoring with your endocrinologist and genetic counselor.